Amir A. Jazaeri

8.7k total citations · 1 hit paper
169 papers, 5.7k citations indexed

About

Amir A. Jazaeri is a scholar working on Oncology, Reproductive Medicine and Immunology. According to data from OpenAlex, Amir A. Jazaeri has authored 169 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 55 papers in Reproductive Medicine and 45 papers in Immunology. Recurrent topics in Amir A. Jazaeri's work include Cancer Immunotherapy and Biomarkers (53 papers), Ovarian cancer diagnosis and treatment (51 papers) and Endometrial and Cervical Cancer Treatments (39 papers). Amir A. Jazaeri is often cited by papers focused on Cancer Immunotherapy and Biomarkers (53 papers), Ovarian cancer diagnosis and treatment (51 papers) and Endometrial and Cervical Cancer Treatments (39 papers). Amir A. Jazaeri collaborates with scholars based in United States, Singapore and United Kingdom. Amir A. Jazaeri's co-authors include Christos Sotiriou, Edison T. Liu, Lisa M. McShane, Philippe Martiat, Soek-Ying Neo, Philip M. Long, Adrian L. Harris, Edward L. Korn, Stephen B. Fox and Laurel W. Rice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Amir A. Jazaeri

152 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

2003 1.5k citations Christos Sotiriou, Amir A. Jazaeri et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amir A. Jazaeri United States	34	2.6k	2.3k	1.8k	858	775	169	5.7k
Aurelia Noske Germany	38	3.2k 1.3×	3.2k 1.4×	1.9k 1.1×	385 0.4×	661 0.9×	102	6.8k
Daniel Rosen United States	37	2.6k 1.0×	1.5k 0.6×	1.0k 0.6×	612 0.7×	1.0k 1.3×	87	4.9k
Ellen L. Goode United States	40	3.1k 1.2×	1.7k 0.7×	1.6k 0.9×	1.4k 1.6×	903 1.2×	148	6.0k
Joshy George United States	34	4.3k 1.7×	2.2k 1.0×	2.0k 1.1×	995 1.2×	1.4k 1.8×	65	7.4k
Christina M. Annunziata United States	37	2.5k 1.0×	2.6k 1.1×	1.0k 0.6×	457 0.5×	1.1k 1.4×	155	5.4k
Ie−Ming Shih United States	38	3.1k 1.2×	1.5k 0.6×	1.6k 0.9×	502 0.6×	2.1k 2.7×	112	6.1k
Steffen Hauptmann Germany	42	2.1k 0.8×	1.4k 0.6×	1.0k 0.6×	523 0.6×	623 0.8×	111	4.9k
Yinhua Yu United States	42	3.8k 1.5×	1.2k 0.5×	1.1k 0.6×	790 0.9×	1.0k 1.3×	82	5.8k
Silvia Darb‐Esfahani Germany	35	2.1k 0.8×	3.3k 1.4×	1.9k 1.1×	348 0.4×	678 0.9×	114	5.9k
Izhak Haviv Australia	29	2.3k 0.9×	1.3k 0.6×	1.2k 0.7×	356 0.4×	660 0.9×	56	4.4k

Countries citing papers authored by Amir A. Jazaeri

Since Specialization

Citations

This map shows the geographic impact of Amir A. Jazaeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir A. Jazaeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir A. Jazaeri more than expected).

Fields of papers citing papers by Amir A. Jazaeri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir A. Jazaeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir A. Jazaeri. The network helps show where Amir A. Jazaeri may publish in the future.

Co-authorship network of co-authors of Amir A. Jazaeri

This figure shows the co-authorship network connecting the top 25 collaborators of Amir A. Jazaeri. A scholar is included among the top collaborators of Amir A. Jazaeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir A. Jazaeri. Amir A. Jazaeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

How, Jeffrey & Amir A. Jazaeri. (2025). Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of COMPASSION-16. Med. 6(1). 100558–100558. 1 indexed citations

Sood, Anil K., et al.. (2024). EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma. Cancer Biomarkers. 39(4). 289–298. 2 indexed citations

Dasari, Santosh K., Reid T. Powell, Mary Sobieski, et al.. (2023). Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). 5546–5546.

Morris, Van K., Amir A. Jazaeri, Shannon N. Westin, et al.. (2023). Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. The Oncologist. 28(7). 618–623. 13 indexed citations

Son, Ji, Heather Lin, Siqing Fu, et al.. (2023). Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer. SHILAP Revista de lepidopterología. 6(1). 10–18. 1 indexed citations

Disis, Mary L., Sarah F. Adams, Jyoti Bajpai, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006624–e006624. 14 indexed citations

Ahmed, Jibran, Bettzy Stephen, Sarina A. Piha‐Paul, et al.. (2023). Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies. Cancer. 130(3). 400–409. 11 indexed citations

Fix, Samantha M., Marie‐Andrée Forget, Donastas Sakellariou-Thompson, et al.. (2022). CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling. Journal for ImmunoTherapy of Cancer. 10(7). e003750–e003750. 29 indexed citations

Mitra, Devarati, Priyadharsini Nagarajan, Andrew J. Bishop, et al.. (2022). Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression. Gynecologic Oncology. 167(3). 483–489. 7 indexed citations

10.

Shaw, Kenna, Fengyi Jin, Shannon N. Westin, et al.. (2022). Clinical implications of tumor-based next-generation sequencing in ovarian cancer.. Journal of Clinical Oncology. 40(16_suppl). 5545–5545.

11.

Fix, Samantha M., Amir A. Jazaeri, & Patrick Hwu. (2021). Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer. Cancer Discovery. 11(3). 560–574. 20 indexed citations

12.

Shang, Stephen, Jiekun Yang, Amir A. Jazaeri, et al.. (2019). Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer. Cancer Research. 79(18). 4599–4611. 44 indexed citations

13.

Amaria, Rodabe N., Chantale Bernatchez, Marie‐Andrée Forget, et al.. (2019). Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers.. Journal of Clinical Oncology. 37(15_suppl). TPS2650–TPS2650. 6 indexed citations

14.

Kumar, Pankaj, Laura W. Dillon, Yoshiyuki Shibata, et al.. (2017). Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation. Molecular Cancer Research. 15(9). 1197–1205. 178 indexed citations

15.

Taylor, Jolyn, Shannon N. Westin, Amir A. Jazaeri, et al.. (2017). N-DUR: Matched pair pharmacodynamics study of neoadjuvant durvalumab in combination with chemotherapy in frontline ovarian cancer. Annals of Oncology. 28. v353–v354.

16.

Jividen, Kasey, Mercedeh Movassagh, Amir A. Jazaeri, & Hui Li. (2014). Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens. Journal of Visualized Experiments. 5 indexed citations

17.

Jazaeri, Amir A., Etsuko Shibata, Jong-Hoon Park, et al.. (2013). Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924. Molecular Cancer Therapeutics. 12(10). 1958–1967. 58 indexed citations

18.

Courtney‐Brooks, Madeleine, Jennifer Scalici, Melissa Henretta, et al.. (2013). Vulvar necrotizing soft tissue infection: A review of a multi-disciplinary surgical emergency and management in the modern era. PubMed. 5. 6–9. 6 indexed citations

19.

Jazaeri, Amir A., Jennifer Bryant, Hui Li, et al.. (2011). Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma. Neoplasia. 13(10). 899–IN16. 57 indexed citations

20.

Jazaeri, Amir A., Christopher S. Awtrey, Gadisetti V.R. Chandramouli, et al.. (2005). Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers. Clinical Cancer Research. 11(17). 6300–6310. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact